Omar Abidi

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Global estimates of diabetes prevalence for 2013 and projections for 2035

Type 2 diabetes in Mauritania: Prevalence of the undiagnosed diabetes, influence of family history and maternal effect

Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Global epidemiology of HIV infection in men who have sex with men

Current and future burden of breast cancer: Global statistics for 2020 and 2040

HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa

Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.

Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries

The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network

Association of C677T transition of the human methylenetetrahydrofolate reductase (MTHFR) gene with male infertility

Carrier Frequencies of Mutations/Polymorphisms in the Connexin 26 Gene ( GJB2 ) in the Moroccan Population

The c.242G>A mutation in LRTOMT gene is responsible for a high prevalence of deafness in the Moroccan population

GJB2 (connexin 26) gene mutations in Moroccan patients with autosomal recessive non-syndromic hearing loss and carrier frequency of the common GJB2–35delG mutation

Association of the MTHFR A1298C Variant with Unexplained Severe Male Infertility

Maternal Effect and Familial Aggregation in a Type 2 Diabetic Moroccan Population

Genetics of breast cancer in African populations: a literature review

Prevalence of the mitochondrial A 1555G mutation in Moroccan patients with non-syndromic hearing loss

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco